The Anarcha, Betsey, Lucy, et al (ABLE) Initiative honors the contributions that these women and others (whose names were not recorded) made to gynecologic surgery. In honoring these women, the ABLE Initiative supports several Diversity, Equity, and Inclusion efforts within AUGS. The ABLE Scholars Travel Award Program is one of the many programs supported by the ABLE Initiative. This program provides funding for residents and fellows to attend PFD Week, AUGS’ Annual Scientific Meeting.
Program Goals
- Identify promising residents and fellows from diverse backgrounds and interests who demonstrate potential to be leaders in the field of urogynecology and pelvic reconstructive surgery
- Provide opportunities for resident applicants who have minimal or no exposure to the field of urogynecology at their residency program
- Provide opportunities for fellows who have limited financial support to attend professional meetings.
- Create a network among recipients and leaders in AUGS for life-long career development and support
Sponsor
ABLE Fund (Managed by the AUGS Foundation)
Prize
- $1,000 travel stipend
- Complimentary meeting registration for PFD Week, AUGS’ Annual Scientific Meeting
Nomination Criteria
- Residents - Any obstetrics and gynecology or urology resident who at the time of the application is not in their first or last year of residency. Applicants must be from an accredited residency program in the US or Canada who are at an institution without a fellowship program and/or access to a urogynecologist during their residency.
- Fellows – Any urogynecology and pelvic reconstructive surgery fellow at an accredited program in the US with limited resources to attend professional development meetings.
- Applicants are a member of an under-represented minority group and/or the LGBTQ+ community
Submission Information
You will need to create a separate login to submit an application. The application portal is NOT linked to your AUGS account.
Application Deadline: February 25, 2025
Submit an Application
Past Recipients
2024
Alexandra Alfonso Castro, MD